|Awarded On||May 20, 2015|
|Title||The Combinatorial Drug Discovery Program (CDDP)|
|Award Mechanism||Core Facility Support Awards|
|Institution/Organization||Texas A&M University System Health Science Center|
|Principal Investigator/Program Director||Peter Davies|
|Cancer Sites||All Sites|
While there have been spectacular advances in our ability to understand the basic mechanisms that contribute to the growth of many types of cancer, there remain significant challenges in translating these discoveries into treatments that are of direct benefit to patients. Part of the problem is that many cancer researchers lack access to the types of specialized resources for drug discovery that are available to scientists working in pharmaceutical companies. The goal of the GCC High Throughput Screening Program, has been to provide Texas’ cancer researchers with access to state-of-the-art facilities and cutting-edge technologies that they can use to translate the results of their research i...